Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human XRCC2 Protein, N-His

Catalog #:   YHA70401 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O43543
Protein length: His40-Cys280
Overview

Catalog No.

YHA70401

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

His40-Cys280

Predicted molecular weight

29.96 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O43543

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

DNA repair protein XRCC2, X-ray repair cross-complementing protein 2, XRCC2

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human XRCC2 protein
References

Relationship between autoimmunity and COPD: an investigation based on proteomic profiling and antinuclear antibody screening., PMID:40329569

Genetic Polymorphisms of DNA Repair Genes and their Influence on Paclitaxel based Chemotherapy Induced Toxicity Reactions in Breast Cancer Patients., PMID:39733420

Discovery of novel xanthohumol C derivatives regulating XRCC2 transcription and expression for the treatment of colorectal cancer., PMID:39731930

Somatic gene mutations involved in DNA damage response/Fanconi anemia signaling are tissue- and cell-type specific in human solid tumors., PMID:39421870

FIGL1 attenuates meiotic interhomolog repair and is counteracted by the RAD51 paralog XRCC2 and the chromosome axis protein ASY1 during meiosis., PMID:39420761

RAD51 Paralogs and RAD51 Paralog Complexes BCDX2 and CX3 Interact with BRCA2., PMID:39416194

The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome., PMID:39359934

Mechanism of BCDX2-mediated RAD51 nucleation on short ssDNA stretches and fork DNA., PMID:39268578

Identifying crucial lncRNAs and mRNAs in hypoxia-induced A549 lung cancer cells and investigating their underlying mechanisms via high-throughput sequencing., PMID:39236027

Targeting proliferating cell nuclear antigen enhances ionizing radiation-induced cytotoxicity in prostate cancer cells., PMID:39219052

Screening of gastric cancer diagnostic biomarkers in the homologous recombination signaling pathway and assessment of their clinical and radiomic correlations., PMID:39206620

c-Myc-XRCC2-FOS axis promotes the proliferation and the resistance to Doxorubicin of NSCLC., PMID:39153434

Anti-inflammatory and DNA Repair Effects of Astragaloside IV on PC12 Cells Damaged by Lipopolysaccharide., PMID:39112916

Association of XRCC2 with breast cancer, a multi-omics analysis at genomic, transcriptomic, and epigenomic level., PMID:39097872

XRCC2 driven homologous recombination subtypes and therapeutic targeting in lung adenocarcinoma metastasis., PMID:39090304

XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo., PMID:39048769

Clinico-genomic findings, molecular docking, and mutational spectrum in an understudied population with breast cancer patients from KP, Pakistan., PMID:38784039

Possible New Candidates Involved to Thalidomide-Related Limbs and Cardiac Defects: A Systems Biology Approach., PMID:38689186

Unraveling the genetics of arsenic toxicity with cellular morphology QTL., PMID:38662777

Interaction between XRCC2 gene polymorphism and abdominal obesity on risk of endometrial carcinoma., PMID:38518807

RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma., PMID:38323009

Association between XRCC2 Arg188His Polymorphism and Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis., PMID:38285766

Exploring homologous recombination repair and base excision repair pathway genes for possible diagnostic markers in hematologic malignancies., PMID:37861816

RAD51 paralogs synergize with RAD51 to protect reversed forks from cellular nucleases., PMID:37843130

Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study., PMID:37774058

Single Nucleotide Polymorphisms in DNA Repair Genes (XRCC1, XRCC2, XRCC3) and Their Association with Radiotherapy Toxicity among Head and Neck Cancer Patients:A Study from South-Western Maharashtra., PMID:37774056

Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer., PMID:37733366

Association of RAD51, XRCC1, XRCC2, and XRCC3 Polymorphisms with Risk of Breast Cancer., PMID:37522793

Structural insights into BCDX2 complex function in homologous recombination., PMID:37344589

Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor., PMID:37344587

RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma., PMID:37333164

Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C., PMID:37253112

Postnatal nutrition environment reprograms renal DNA methylation patterns in offspring of maternal protein-restricted stroke-prone spontaneously hypertensive rats., PMID:37125041

Differential expression of DNA repair genes and treatment outcome of chemoradiotherapy (CRT) in cervical cancer., PMID:36963733

Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer., PMID:36896237

Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability., PMID:36374936

Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index., PMID:36213825

Homologous recombination-deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants., PMID:36099300

Understanding Role of DNA Repair and Cytochrome p-450 Gene Polymorphisms in Cervical Cancer Patient Treated With Concomitant Chemoradiation., PMID:35996502

Strand annealing and motor driven activities of SMARCAL1 and ZRANB3 are stimulated by RAD51 and the paralog complex., PMID:35801922

Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin., PMID:35763645

The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis., PMID:35691022

PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells., PMID:35643812

Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis., PMID:35617463

A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh., PMID:35277785

Homologous recombination DNA repair gene RAD51, XRCC2 & XRCC3 polymorphisms and breast cancer risk in South Indian women., PMID:35061678

Genetics of ovarian insufficiency and defects of folliculogenesis., PMID:34794894

XRCC2 Arg188His polymorphism and colorectal cancer risk: a meta-analysis., PMID:34648414

Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer., PMID:34587437

A comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects., PMID:34585473

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human XRCC2 Protein, N-His [YHA70401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only